Clinical Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SYS6045 in Patients With HER2-Positive, Expressing, or Mutated Advanced Malignant Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Advanced Solid Tumors
Related studies linked through entity extraction aliases.
Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Treating Nectin-4-positive Advanced Solid Tumors With R-Star001 (Nectin-4-CART-IL18)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study of HDM2012 in Patients With Advanced Solid Tumor
- Status
- RECRUITING
- Phase
- PHASE1
A Study of MRG006A in the Treatment of Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Assess Safety, Tolerability and Drug Levels of BMS-986504 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of AK146D1 for Injection in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of QLS5133 Monotherapy in Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Safety, Tolerability and Preliminary Efficacy of NTS071 in Subjects With Advanced Solid Tumors Harboring a TP53 Y220C Mutation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Phase I Open-Label Study of P1101 Followed by P1801 in Advanced Solid Tumors
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1
Study of CHO-A04 in Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Multi-cohort, Single-arm, Phase II Study of the Efficacy and Side Effects of Cisplatin Plus Gemcitabine in the Treatment of PD1 Failure or Intensive Treatment of Some Rare Tumors
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment
- Status
- RECRUITING
- Phase
- PHASE1
Study of CM518D1 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of HDM2005 in Patients With Advanced Solid Tumor
- Status
- RECRUITING
- Phase
- PHASE1
Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DAT-1604 in Advanced Solid Tumor
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Phase I Study of HBT-708 for Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2